SCHEMBL2667918

SCHEMBL2667918

FC1CC(c2ccc(I)cc2)(c2nnc(C3CC3)n2C2CC2)C1

nearest known ligand 0.78

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.78
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2667625 1.00 HSD11B1 (0.78) HSD11B1CYP3A4CYP2D6CYP2C9
SCHEMBL16868571 0.80 HSD11B1 (0.83) HSD11B1CYP3A4CYP2D6CYP2C9
SCHEMBL4528572 0.76 HSD11B1 (0.63) HSD11B1
SCHEMBL13902471 0.75 HSD11B1 (0.60) HSD11B1
SCHEMBL4102633 0.75 HSD11B1 (0.66) HSD11B1
SCHEMBL4102630 0.75 HSD11B1 (0.66) HSD11B1
SCHEMBL13902468 0.75 HSD11B1 (0.66) HSD11B1
SCHEMBL4360892 0.74 HSD11B1 (0.60) HSD11B1
SCHEMBL2667471 0.74 HSD11B1 (0.79) HSD11B1
SCHEMBL5638283 0.71 HSD11B1 (0.56) HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004110375-A2 COMBINATION THERAPY FOR THE TREATMENT OF DIABETES MERCK & CO., INC. (US) 2004-12-23 WO disclosed